Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk

Obstructive sleep apnoea (OSA) is associated with increased cardiovascular disease (CVD) morbidity and mortality. It is accepted that OSA and obesity commonly coexist. The American Academy of Sleep Medicine recommends dietary-induced weight loss and exercise as lifestyle treatment options for OSA. H...

Full description

Bibliographic Details
Main Authors: Devon A. Dobrosielski, Christopher Papandreou, Susheel P. Patil, Jordi Salas-Salvadó
Format: Article
Language:English
Published: European Respiratory Society 2017-06-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/26/144/160110.full
id doaj-215edad0302847788835653abda044f0
record_format Article
spelling doaj-215edad0302847788835653abda044f02020-11-25T01:24:51ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172017-06-012614410.1183/16000617.0110-20160110-2016Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease riskDevon A. Dobrosielski0Christopher Papandreou1Susheel P. Patil2Jordi Salas-Salvadó3 Dept of Kinesiology, Towson University, Towson, MD, USA Human Nutrition Dept, Hospital Universitari Sant Joan, Institut d'Investigació Sanitaria Pere Virgili, Universitat Rovira i Virgili, Reus, Spain Dept of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA Human Nutrition Dept, Hospital Universitari Sant Joan, Institut d'Investigació Sanitaria Pere Virgili, Universitat Rovira i Virgili, Reus, Spain Obstructive sleep apnoea (OSA) is associated with increased cardiovascular disease (CVD) morbidity and mortality. It is accepted that OSA and obesity commonly coexist. The American Academy of Sleep Medicine recommends dietary-induced weight loss and exercise as lifestyle treatment options for OSA. However, most clinical trials upon which this recommendation is based have focused on establishing the effectiveness of calorie-restricted, often low-fat diets for improving OSA severity, whereas less attention has been given to the means through which weight loss is achieved (e.g. altered dietary quality) or whether diet or exercise mediates the associations between reduced weight, improved OSA severity and the CVD substrate. The current evidence suggests that the benefits of a low-carbohydrate or Mediterranean diet in overweight and obese individuals go beyond the recognised benefits of weight reduction. In addition, exercise has an independent protective effect on vascular health, which may counter the increased oxidative stress, inflammation and sympathetic activation that occur in OSA patients. This review aims to expand our understanding of the effects of diet and exercise on OSA and associated CVD complications, and sets the stage for continued research designed to explore optimal lifestyle strategies for reducing the CVD burden in OSA patients.http://err.ersjournals.com/content/26/144/160110.full
collection DOAJ
language English
format Article
sources DOAJ
author Devon A. Dobrosielski
Christopher Papandreou
Susheel P. Patil
Jordi Salas-Salvadó
spellingShingle Devon A. Dobrosielski
Christopher Papandreou
Susheel P. Patil
Jordi Salas-Salvadó
Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
European Respiratory Review
author_facet Devon A. Dobrosielski
Christopher Papandreou
Susheel P. Patil
Jordi Salas-Salvadó
author_sort Devon A. Dobrosielski
title Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
title_short Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
title_full Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
title_fullStr Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
title_full_unstemmed Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
title_sort diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
publisher European Respiratory Society
series European Respiratory Review
issn 0905-9180
1600-0617
publishDate 2017-06-01
description Obstructive sleep apnoea (OSA) is associated with increased cardiovascular disease (CVD) morbidity and mortality. It is accepted that OSA and obesity commonly coexist. The American Academy of Sleep Medicine recommends dietary-induced weight loss and exercise as lifestyle treatment options for OSA. However, most clinical trials upon which this recommendation is based have focused on establishing the effectiveness of calorie-restricted, often low-fat diets for improving OSA severity, whereas less attention has been given to the means through which weight loss is achieved (e.g. altered dietary quality) or whether diet or exercise mediates the associations between reduced weight, improved OSA severity and the CVD substrate. The current evidence suggests that the benefits of a low-carbohydrate or Mediterranean diet in overweight and obese individuals go beyond the recognised benefits of weight reduction. In addition, exercise has an independent protective effect on vascular health, which may counter the increased oxidative stress, inflammation and sympathetic activation that occur in OSA patients. This review aims to expand our understanding of the effects of diet and exercise on OSA and associated CVD complications, and sets the stage for continued research designed to explore optimal lifestyle strategies for reducing the CVD burden in OSA patients.
url http://err.ersjournals.com/content/26/144/160110.full
work_keys_str_mv AT devonadobrosielski dietandexerciseinthemanagementofobstructivesleepapnoeaandcardiovasculardiseaserisk
AT christopherpapandreou dietandexerciseinthemanagementofobstructivesleepapnoeaandcardiovasculardiseaserisk
AT susheelppatil dietandexerciseinthemanagementofobstructivesleepapnoeaandcardiovasculardiseaserisk
AT jordisalassalvado dietandexerciseinthemanagementofobstructivesleepapnoeaandcardiovasculardiseaserisk
_version_ 1725116752634839040